MAIA Biotechnology, Inc.
MAIA
$1.12
-$0.06-5.09%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 97.44% | 16.57% | 36.84% | -23.49% | -35.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 123.49% | 35.40% | 37.39% | -21.53% | -15.48% |
| Operating Income | -123.49% | -35.40% | -37.39% | 21.53% | 15.48% |
| Income Before Tax | -225.41% | 39.78% | 44.01% | 42.91% | 43.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -225.41% | 39.78% | 44.01% | 42.91% | 43.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -225.41% | 39.78% | 44.01% | 42.91% | 43.88% |
| EBIT | -123.49% | -35.40% | -37.39% | 21.53% | 15.48% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -134.24% | 55.86% | 64.41% | 64.71% | 67.88% |
| Normalized Basic EPS | -134.08% | 55.86% | 64.43% | 64.69% | 67.86% |
| EPS Diluted | -134.24% | 55.86% | 64.41% | 64.71% | 67.88% |
| Normalized Diluted EPS | -134.08% | 55.86% | 64.43% | 64.69% | 67.86% |
| Average Basic Shares Outstanding | 38.95% | 36.47% | 57.35% | 61.74% | 74.72% |
| Average Diluted Shares Outstanding | 38.95% | 36.47% | 57.35% | 61.74% | 74.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |